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Low metastatic parent B16 melanoma and isolated B16-Fl cell lines have a third actin designated as pm(AX:previously). pm actin is scantily or 
not at all detected in highly metastatic cell lines, such as Bl6-FlO and BL6. To directly assess the physiological role of pm in phenotypic changes 
of B16 melanoma, we transfected expression plasmids ofbm into B16-FIO cells. The actin expressed in the transfectants is located largely in cytoskele- 
tal fractios. The transfectants exhibited a larger number of stress fibers and a lower invasiveness than did the recipient cells. Thus, /?m actin plays 
an important role in the organization of actin stress fibers, the result being a decrease in invasiveness of B16 melanoma. 
Actin; DNA transfer; Stress fiber; Cytoskeleton 
1. INTRODUCTION 
A third actin @m) detected in mouse B16 melanoma 
is a newly identified type of cytoskeletal actin [ 1,2]. The 
amino acid sequence of this actin, determined by the 
nucleotide sequence of the cDNA, differed fromfl actin 
at the 28th amino acid @, arginine; pm, leucine) 
(Fig. lA), and at five amino acids from y actin. In the 
nucleotide sequence of pm cDNA, there were two sites 
with one base change, one site of one base insertion and 
four regions of deletion compared with hithertofore 
known mouse ,& actin [3]. Therefore, ,0m actin is closely 
related to ,& actin, which consists of a multiple gene 
family containing active and pseudogenes [4,5]. Pm was 
co-expressed with /3 and y actins in parent B16 
melanoma and the B16-Fl cell lines, both of which are 
low metastatic, yet little or not at all in the highly 
metastatic B16-FlO cell line, indicating inverse correla- 
tion of pm actin expression and metastatic ability of 
B 16-melanoma [ 1,6]. Previously, mutant fi actin which 
has one amino acid exchange at the 244th amino acid 
(mutant ,0, aspartic acid; p, glycine) was reported in 
reference of tumor progression and disorganization of 
cytoskeleton [7-91. Leavitt et al. [lO,l I] showed that 
the expression of mutant p actin in human fibroblast 
KD cells caused tumor progression, by gene transfer ex- 
periments of mutant fl actin DNA. The site of amino 
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acid exchange is different betweenpm and mutant p ac- 
tin, which may correspond to inverse function in the 
organization of cytoskeleton and tumor phenotypes. 
To investigate the physiological role of Pm actin, we 
transfected pm actin cDNA into highly metastatic 
B16-FlO cells expressing no pm actin and analyzed the 
nature of the transfectants. 
2. MATERIALS AND METHODS 
2.1. Cells and DNA transfection 
B16-Fl and FlO, the origin and properties of which were described 
by I.J. Fidler 1121, were grown in Eagle’s minimum essential medium 
(MEM, Nissui) supplemented with 10% fetal bovine serum (FBS, 
Gibco), bicarbonate-buffered (3.7 g/liter) in a moist atmosphere of 
10% CO2 and 90% air. An expression vector was constructed from 
Pm actin cDNA and 5’ UTR region containing human fl actin pro- 
moter [13] and pUC18 (pwA). Another one was constructed from 
pBR322 plasmid containing mouse mammary tumor virus LTR 1141, 
inducible by dexamethasone, pm actin cDNA and Eco gpt gene 
(pMMA). As the Eco gpt gene was not effective as a genetic marker 
in B16-FlO cells, pSV2-neo (1 pg) was co-transfected with the plasmid 
(10 pg) into Blh-melanoma FlO cells (10’ cells/dish) by the calcium 
phosphate precipitation method. G-41 8 (600 /g/ml) selection was 
performed for 7 days and independent clonal G418’ cells were 
isolated. Total proteins and Triton X-100 insoluble cytoskeletal frac- 
tions were obtained from 10’ transfectants, and then two dimensional 
gel electrophoresis and Western blot analysis, and rhodamine- 
phalloidin staining was performed as described previously [6]. 
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2.2. In vitro invasion analysis 
In vitro invasion assay was carried out by the method of Albini et 
al. [IS] using polycarbonate filters, with 8 pm pore size (Nuclepore, 
CA), which were coated with 50pg of the basement membrane 
matrigel. 
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(A) 
23 28 33 
Pm Glv Asp ASP Ala Pro Ala Val Phe Pro Ser 
1' Glv ASP ASP Ala Pro Ala Val Phe Pro Ser 
(6) 
FIO!Lkx 
Fig. 1. (A) The amino terminal side sequences of mouse flrn actin 
containing a different amino acid from fl actin, whereas the carboxyl 
side sequences are the same as b actin. (B) Expression of pm actin in 
the transfectants (B16-FlO) carrying pm cDNA grown with or 
without 5 pM dexamethasone for 3 days. Cells (10’) were harvested 
and treated with 9 ~01s of cold acetone. The acetone powder was 
dissolved in O’Farrell’s lysis buffer, and the sample corresponding to 
lo6 cells was analyzed with two dimensional gel electrophoresis and 
Western blot immunostaining, using anti-actin antibody and 
peroxidase conjugated second antibody. The AM10-33 clone is a 
clonal transfectant with pMMA, the A,JlO-53 and 42 were 
independent clones transfected with pH/3A. 
3. RESULTS 
The transfectants were cloned and the actin expres- 
sion was examined by Western blot analysis, using anti- 
actin antibody. Independent clones, A/310-42 and 
A/310-53 carrying pH,8A plasmid expressed pm actin 
(Fig. 1B). In clone AM10-33 carrying pMMA, pm actin 
was induced only when cultured with 5 ,uM dex- 
amethasone, but not without dexamethasone (Fig. 1B). 
Exogenous plasmid DNA containing pm cDNA in these 
three clones was detected as extra DNA bands by 
Southern blot analysis (data not shown). Since B16-FlO 
(A) (W 
Fig. 2. Distribution of flrn actin in the transfectants. 10’ cells were 
harvested and extracted with PBS-buffer containing 0.5% Triton 
X-100 at 4°C for 10 min, and Triton X-100 insoluble cytoskeletal 
fractions (A) and soluble fractions (B) were prepared and dissolved 
in equal volumes of lysis buffer. The samples corresponding to 10” 
cells were used for two dimensional gel electrophoresis and Western 
blot analysis with anti-actin antibody. 
cells did not express ,8m actin irrespective of treatment 
with dexamethasone (Fig. 1 B), the ,!3m actin expression 
in B16-FlO transfectants was derived from the ex- 
ogenous DNA plasmid. Densitometric measurement 
showed that the relative proportion of,& to y actin @3/y) 
was unchanged between FlO and transfectants (data 
not shown). 
To investigate the distribution of pm actin in the 
transfectants, we isolated the cytoskeletal fractions and 
Triton X-100 soluble fractions. Fig. 2A shows that ,f?m 
actin expressed in AMlO- cultured with 5 PM dex- 
amethasone located more in cytoskeletal fractions than 
in the Triton X-100 soluble fractions (Fig. 2B) as com- 
pared with,& and y actin. The amounts ofp and y actins 
in cytoskeletal fractions were slightly larger than in 
soluble fractions, but the ratio of P/y actin in both 
fractions was much the same. In other transfectants, 
;1010-42 and A@lO-53, the same phenomena were 
found (data not shown). 
We investigated the cytoskeletal organization of 
B16-FlO transfectants expressing pm actin. AM10-33 
cultured with dexamethasone and A,&lO-53 showed 
more actin stress fibers than the non-induced cells and 
recipient B16-FlO cells (Fig. 3). The induction of pm 
and increase in actin stress fibers were reversible 
phenomena depending on dexamethasone treatment 
(data not shown). 
To investigate the effect of pm actin on cell in- 
vasiveness, we carried out an in vitro analysis using 
matrigel-coated filters. AM10-33 cells cultured under 
pm inducible conditions showed a lower penetration 
than did the B16-FlO cells, irrespective of the treatment 
of the recipient with dexamethasone (Fig. 4A). 
A/310-53 and A,810-42 cells, constitutively expressing 
Pm, also showed lower invasiveness than did B16-FlO 
cells. The invasiveness of A,&lO-53 and AJlO-42 
decreased to much the same level seen in the B16-Fl 
cells (Fig. 4B). On the other hand, FlO transfected 
pSV2-neo (NeolO) showed no significant reduction in 
in vitro invasiveness. 
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Fig. 3 
3.7% 
in PB 
moun 
8. Organization of actin stress fibers associated with expression of pm actin. The cells AM10-33 were grown without (A) or with (B) 5 ~ pM 
nethasone for 3 days. C, D indicated the staining of FlO and AplO-53, respectively. The cells were cultured on cover glasses and fixed with 
formaldehyde in phosphate-buffered saline (PBS) for 30 min at room temperature, then were made permeable with 0.1% Triton X -100 
;S for 2 min. Staining with rhodamine-conjugated phalloid~n was carried out for 30 min. After a wash with PBS, the preparations were 
ted with 90% glycerol- 10% PBS containing 0.1 qo 2/Y-mercaptoethanoi and observed under a fluorescence microscope (Olympus, Tok :yo). 
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Fig. 4. fn vitro invasion assay of@m actin transfectants. B16-FI@‘I), 
Bl6-Fl~FlO), and AM10-33 were cultured with [+Dex) or without 
5 FM dexamethasone for 3 days in (A). in (B), FI, FIQ, WlO-53, 
A,&lO-42 and pSV2-neo-transferred FlO (NeolO) were cultured and 
harvested. Cells (3 x IO’), suspended in DMEM containing 0.1% 
BSA, were added to the upper compartment of Boyden chambers and 
incubated at 37°C in 10% CO2 for 4 h. The lower compartments of 
the chambers were filled with conditioned medium, obtained by 
incubating NIH 3T3 cells for 24 h in serum-free medium containing 
250 mg ascorbate per liter. The number of the ceils penetrated 
through the matrigel coated filters was counted. Each column 
indicates the mean of triplicate samples; bar, SE. The number of cells 
per field was evaluated by Student’s r-test. P value: AM lo-33 + Dex 
versus AMf0-33 and FlO+ Dex, <O.Ol; AXIltl-33 versus FlO+ Deu, 
>0.05; A,&lO-43 and A,810-42 versus F10, <O.Ol; NeotO versus IT:]@, 
>O*(f5. 
4. DISCUSSION 
We reported that the B16-FI ceil line, expressing ,&m 
actin at a high level, has a larger number of actin stress 
fibers and a lower metastatic potential than did the 
B 16-F 10 cell ine not expressing pm act in [ti]. ,&m actin 
was incorporated into the cytoskeleton of B16-Fl cells 
as seen with,& and y actin [6], and had the DNase I bin- 
ding potential seen in other native actin species [Z]. In- 
duction of the Pm expression derived from exogenous 
,f3m cDNA was associated with increase in number of 
actin stress fibers and decrease in the in vitro invasion 
across matrigel-coated filters. Thus, pm actin seems to
promote construction of the stress fibers, leading to 
reduction of the cell motility and/or tlexibility. Since 
there was no difference in the amount of @+ y actins 
between I?1 and FlO, ,8m actin is an additive population 
in B16-Fl. High efficiency of incorporation offlm actin 
into cytoskeletal fractions in the transfectants appears 
to indicate higher competence ofam actin to form actin 
filaments than fl and 3’ actins. We previously observed 
much the same efficiency in jncorporatioll of,&m, fi and 
y actins into cytoskeletal fraction of B16-Fl. The high 
ratio of pm actin in the cytoskeletal fraction of the 
transf~~tants might be due to intracellular conditions, 
which are advantageous to nuclear formations, incor- 
poration into actin filaments and/or interaction with 
actin-associatiIlg proteins. A mutant fi actin, which has 
one amino acid exchange (glycine, fi; aspartic acid, mu- 
tant .& at amino acid 244), had less polymerizing activity 
in vitro and in vivo, leading to disor~aIlization of the 
actin stress fibers in KU-fibroblast [T--9]. Leavitt et al, 
noted that transfer of the mutant ,8 actin into a 
transformed but low tumorigeilic cell line increased the 
malignancy and altered the organization of the 
microfilaments [ 10,ll J. These inverse biochemical and 
biological functions of this mutant ,15’ actin against ,8m 
actin in B16 melanoma may be attributed to the dif- 
ference in the site of amino acid change. Regardless of 
low expression of pm actin in UlBFlO transfectants, 
the integrity of actin stress fibers increased and the 
malignancy decreased, showing efficient biological 
functions of $rn actin on such cellular phenotypes. It 
remains to be examined whether the integrity of actin 
stress fibers is restored by other exogenously transfer- 
red actin isomers, such as ,&, 3;, or LY actin. 
Changes of cytoskeletal proteins are associated wirh 
malignant transformation and/or progression of 
various cells and it is widely assumed that these changes 
are involved in the alteration of cell morphology, flex- 
ibility and motility [16-19]. In addition to our finding 
for ,&m actin in B16 melanoma, there are reports on the 
depression of a third functionally normal acrin 
associated with cell transformation. In chick embryo 
cells 1201, and rat and mouse fibroblast cell lines 1211, 
cy type actin was either decreased or disappeared in the 
transformants. We also found that cy actin jdent~fied as 
the smooth muscle type was expressed in a normal rat 
3Yl cell line but decreased or was absent in the malig- 
nant counterparts [22]. The cy actin of smooth muscle 
type detected in human pigment tissues tends to 
decrease in malignant melanoma tissues f23]. Thus, 
alteration in expression of ~ytoskeletal actin often ac- 
companies malignant transformation and/or progres- 
sion. However, the role of the n! type actin in 
non-muscle cells remains to be investigated. The func- 
tional differences among @m, ,8, y and N actin are an 
interesting subject. Because there is no method to 
reproducibIy separate actin isomers n~aintai~lijlg the 
native functions, a new method for isolation has to be 
developed. 
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